Otsuka

Discussion in 'Lundbeck' started by anonymous, Dec 1, 2016 at 11:38 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So Otsuka lays off people but at least gives them a minimum of 8 weeks severance then one week per year. World class Lundbeck lets people go that are 90% to goal with no severance....
     

  2. anonymous

    anonymous Guest

    Why would you expect severance after being fired? We haven't had any layoffs or reorgs this year so I assume you were let go for performance reasons. If that's the case then there isn't a company out there who would be paying you severance, much less 8wks worth
     
  3. anonymous

    anonymous Guest

    Companies seldom use sales numbers, i.e. not hitting quota, as a reason to fire someone. Look at the increase from T2 to T3 in Rexulti goals! The company damn well knew that the increase did not reflect what was going on in the market. This was simply a way to control bonus payout. The apathy out here is the worst I've ever seen. We've had nothing of any value to promote Trin since launch, save some stupid "patient profile". You will see more people leave voluntarily in 2017, than ever before.
     
  4. anonymous

    anonymous Guest

    When managers listen more to reps from the company they copromote with than their own reps, there is a problem. Especially when you have facts that back you up.
     
  5. anonymous

    anonymous Guest

    The reality is they don't need anyone one of us long term. They have a product and we have a service. The day they don't see value, the senior management team makes the call to cut people and the people at the top are paid generously to watch the "little people" get slaughtered.

    Consider this when you sell out yourself to LU, when it's all said and done they will send you to the slaughterhouse when it's convenient for them and the shareholders that we as employees take no part of.

    The best is hearing that the USA makes up around 50% of the financial output yet we don't have a seat at the table. No ability to get shares, awarded shares/options etc. LU wants to be "world class" but doesn't compensate as one would.

    With all the money we are making for he global LU platform hopefully they find promising medications to acquire otherwise we are just another day closer to the slaughterhouse.
     
  6. anonymous

    anonymous Guest

    1. You are right about being treated as second rate. Danish execs get free company audis, generous stock options, etc. you are the help.

    2. That said from a rep perspective, at least US afilliate still has jobs. Since Global can't get European payers to cover our me too psych products, European commercial org has been burned to the ground.

    3. We have one viable compound being tested in humans (one!!!). Everything else is high risk and 10+ years away from approval. That's crappy for a biotech with a hundred people. Our company has 5000. There is no future here. This company killed itself with decisions made 10+ years ago.
     
  7. anonymous

    anonymous Guest

    You can look at the spin being put forth by Deerfield all you want. The facts remain the same. Otsuka and Takeda call the shots and control the bulk of the dollars being brought in on the psych side. The pipeline is non existent. There is no long term future. If you aren't looking to leave, you are either naive or lazy.